 | • レポートコード：MRC2102QY3015 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の豚コレラワクチン市場について種類別（組織培養発生、細胞株発生）、用途別（政府入札、市場販売）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・豚コレラワクチン市場の概要 ・世界の主要地域別豚コレラワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の豚コレラワクチン市場規模2015-2026：種類別（組織培養発生、細胞株発生） ・世界の豚コレラワクチン市場規模2015-2026：用途別（政府入札、市場販売） ・豚コレラワクチンの米国市場規模2015-2020 ・豚コレラワクチンのヨーロッパ市場規模2015-2020 ・豚コレラワクチンの中国市場規模2015-2020 ・豚コレラワクチンの日本市場規模2015-2020 ・豚コレラワクチンの東南アジア市場規模2015-2020 ・豚コレラワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・豚コレラワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・豚コレラワクチンの市場動向・機会・課題 ・調査の結論 |
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The classification of Classical Swine Fever Vaccines includes Tissue Culture Origin and Cell Line Origin. The proportion of Tissue Culture Origin in 2016 is about 60%. And the proportion of Cell Line Origin in 2016 is about 40%. Market competition is intense WINSUN, CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Classical Swine Fever Vaccines industry will be more and more popular in the future.
Market Analysis and Insights: Global Classical Swine Fever Vaccines Market
The global Classical Swine Fever Vaccines market size is projected to reach US$ 173.8 million by 2026, from US$ 148.2 million in 2020, at a CAGR of 2.7% during 2021-2026.
Global Classical Swine Fever Vaccines Scope and Market Size
The global Classical Swine Fever Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Classical Swine Fever Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Source, the Classical Swine Fever Vaccines market is segmented into
Tissue Culture Origin
Cell Line Origin
Segment by Sales Channel, the Classical Swine Fever Vaccines market is segmented into
Government Tender
Market Sales
The Classical Swine Fever Vaccines market is analysed and market size information is provided by regions (countries). Segment by Sales Channel, the Classical Swine Fever Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Source, and by Sales Channel segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Classical Swine Fever Vaccines Market Share Analysis
Classical Swine Fever Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Classical Swine Fever Vaccines business, the date to enter into the Classical Swine Fever Vaccines market, Classical Swine Fever Vaccines product introduction, recent developments, etc.
The major vendors covered:
WINSUN
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
1 Classical Swine Fever Vaccines Market Overview
1.1 Classical Swine Fever Vaccines Product Scope
1.2 Classical Swine Fever Vaccines Segment by Source
1.2.1 Global Classical Swine Fever Vaccines Sales by Source (2020-2026)
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Classical Swine Fever Vaccines Segment by Sales Channel
1.3.1 Global Classical Swine Fever Vaccines Sales Comparison by Sales Channel (2020-2026)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Classical Swine Fever Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Classical Swine Fever Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Classical Swine Fever Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Classical Swine Fever Vaccines Price Trends (2015-2026)
2 Classical Swine Fever Vaccines Estimate and Forecast by Region
2.1 Global Classical Swine Fever Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Classical Swine Fever Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Classical Swine Fever Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Classical Swine Fever Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Classical Swine Fever Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Classical Swine Fever Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Classical Swine Fever Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Classical Swine Fever Vaccines Estimates and Projections (2015-2026)
2.4.3 China Classical Swine Fever Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Classical Swine Fever Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Classical Swine Fever Vaccines Estimates and Projections (2015-2026)
2.4.6 India Classical Swine Fever Vaccines Estimates and Projections (2015-2026)
3 Global Classical Swine Fever Vaccines Competition Landscape by Players
3.1 Global Top Classical Swine Fever Vaccines Players by Sales (2015-2020)
3.2 Global Top Classical Swine Fever Vaccines Players by Revenue (2015-2020)
3.3 Global Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Classical Swine Fever Vaccines as of 2019)
3.4 Global Classical Swine Fever Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Classical Swine Fever Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Classical Swine Fever Vaccines Players (Opinion Leaders)
4 Global Classical Swine Fever Vaccines Market Size by Source
4.1 Global Classical Swine Fever Vaccines Historic Market Review by Source (2015-2020)
4.1.1 Global Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
4.1.2 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2015-2020)
4.1.3 Global Classical Swine Fever Vaccines Price by Source (2015-2020)
4.2 Global Classical Swine Fever Vaccines Market Estimates and Forecasts by Source (2021-2026)
4.2.1 Global Classical Swine Fever Vaccines Sales Forecast by Source (2021-2026)
4.2.2 Global Classical Swine Fever Vaccines Revenue Forecast by Source (2021-2026)
4.2.3 Global Classical Swine Fever Vaccines Price Forecast by Source (2021-2026)
5 Global Classical Swine Fever Vaccines Market Size by Sales Channel
5.1 Global Classical Swine Fever Vaccines Historic Market Review by Sales Channel (2015-2020)
5.1.1 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
5.1.2 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2015-2020)
5.1.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2015-2020)
5.2 Global Classical Swine Fever Vaccines Market Estimates and Forecasts by Sales Channel (2021-2026)
5.2.1 Global Classical Swine Fever Vaccines Sales Forecast by Sales Channel (2021-2026)
5.2.2 Global Classical Swine Fever Vaccines Revenue Forecast by Sales Channel (2021-2026)
5.2.3 Global Classical Swine Fever Vaccines Price Forecast by Sales Channel (2021-2026)
6 United States Classical Swine Fever Vaccines Market Facts & Figures
6.1 United States Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
6.2 United States Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
6.3 United States Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
7 Europe Classical Swine Fever Vaccines Market Facts & Figures
7.1 Europe Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
7.2 Europe Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
7.3 Europe Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
8 China Classical Swine Fever Vaccines Market Facts & Figures
8.1 China Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
8.2 China Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
8.3 China Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
9 Japan Classical Swine Fever Vaccines Market Facts & Figures
9.1 Japan Classical Swine Fever Vaccines Sales Market Share by Company (3015-3030)
9.2 Japan Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
9.3 Japan Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
10 Southeast Asia Classical Swine Fever Vaccines Market Facts & Figures
10.1 Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
10.3 Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
11 India Classical Swine Fever Vaccines Market Facts & Figures
11.1 India Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
11.2 India Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
11.3 India Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
12 Company Profiles and Key Figures in Classical Swine Fever Vaccines Business
12.1 WINSUN
12.1.1 WINSUN Corporation Information
12.1.2 WINSUN Business Overview
12.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 WINSUN Classical Swine Fever Vaccines Products Offered
12.1.5 WINSUN Recent Development
12.2 CAHIC
12.2.1 CAHIC Corporation Information
12.2.2 CAHIC Business Overview
12.2.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CAHIC Classical Swine Fever Vaccines Products Offered
12.2.5 CAHIC Recent Development
12.3 Merial
12.3.1 Merial Corporation Information
12.3.2 Merial Business Overview
12.3.3 Merial Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merial Classical Swine Fever Vaccines Products Offered
12.3.5 Merial Recent Development
12.4 MSD Animal Health
12.4.1 MSD Animal Health Corporation Information
12.4.2 MSD Animal Health Business Overview
12.4.3 MSD Animal Health Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 MSD Animal Health Classical Swine Fever Vaccines Products Offered
12.4.5 MSD Animal Health Recent Development
12.5 Chopper Biology
12.5.1 Chopper Biology Corporation Information
12.5.2 Chopper Biology Business Overview
12.5.3 Chopper Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Chopper Biology Classical Swine Fever Vaccines Products Offered
12.5.5 Chopper Biology Recent Development
12.6 Ceva
12.6.1 Ceva Corporation Information
12.6.2 Ceva Business Overview
12.6.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ceva Classical Swine Fever Vaccines Products Offered
12.6.5 Ceva Recent Development
12.7 ChengDu Tecbond
12.7.1 ChengDu Tecbond Corporation Information
12.7.2 ChengDu Tecbond Business Overview
12.7.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 ChengDu Tecbond Classical Swine Fever Vaccines Products Offered
12.7.5 ChengDu Tecbond Recent Development
12.8 Veterinary
12.8.1 Veterinary Corporation Information
12.8.2 Veterinary Business Overview
12.8.3 Veterinary Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Veterinary Classical Swine Fever Vaccines Products Offered
12.8.5 Veterinary Recent Development
12.9 Ringpu Biology
12.9.1 Ringpu Biology Corporation Information
12.9.2 Ringpu Biology Business Overview
12.9.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ringpu Biology Classical Swine Fever Vaccines Products Offered
12.9.5 Ringpu Biology Recent Development
12.10 Qilu Animal
12.10.1 Qilu Animal Corporation Information
12.10.2 Qilu Animal Business Overview
12.10.3 Qilu Animal Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Qilu Animal Classical Swine Fever Vaccines Products Offered
12.10.5 Qilu Animal Recent Development
12.11 DHN
12.11.1 DHN Corporation Information
12.11.2 DHN Business Overview
12.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 DHN Classical Swine Fever Vaccines Products Offered
12.11.5 DHN Recent Development
12.12 CAVAC
12.12.1 CAVAC Corporation Information
12.12.2 CAVAC Business Overview
12.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.12.4 CAVAC Classical Swine Fever Vaccines Products Offered
12.12.5 CAVAC Recent Development
12.13 Komipharm
12.13.1 Komipharm Corporation Information
12.13.2 Komipharm Business Overview
12.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Komipharm Classical Swine Fever Vaccines Products Offered
12.13.5 Komipharm Recent Development
12.14 Agrovet
12.14.1 Agrovet Corporation Information
12.14.2 Agrovet Business Overview
12.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Agrovet Classical Swine Fever Vaccines Products Offered
12.14.5 Agrovet Recent Development
12.15 Bioveta
12.15.1 Bioveta Corporation Information
12.15.2 Bioveta Business Overview
12.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Bioveta Classical Swine Fever Vaccines Products Offered
12.15.5 Bioveta Recent Development
12.16 Jinyu Bio-Technology
12.16.1 Jinyu Bio-Technology Corporation Information
12.16.2 Jinyu Bio-Technology Business Overview
12.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Products Offered
12.16.5 Jinyu Bio-Technology Recent Development
12.17 Institutul Pasteur
12.17.1 Institutul Pasteur Corporation Information
12.17.2 Institutul Pasteur Business Overview
12.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Institutul Pasteur Classical Swine Fever Vaccines Products Offered
12.17.5 Institutul Pasteur Recent Development
12.18 MVP
12.18.1 MVP Corporation Information
12.18.2 MVP Business Overview
12.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.18.4 MVP Classical Swine Fever Vaccines Products Offered
12.18.5 MVP Recent Development
12.19 Tecon
12.19.1 Tecon Corporation Information
12.19.2 Tecon Business Overview
12.19.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Tecon Classical Swine Fever Vaccines Products Offered
12.19.5 Tecon Recent Development
13 Classical Swine Fever Vaccines Manufacturing Cost Analysis
13.1 Classical Swine Fever Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Classical Swine Fever Vaccines
13.4 Classical Swine Fever Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Classical Swine Fever Vaccines Distributors List
14.3 Classical Swine Fever Vaccines Customers
15 Market Dynamics
15.1 Classical Swine Fever Vaccines Market Trends
15.2 Classical Swine Fever Vaccines Opportunities and Drivers
15.3 Classical Swine Fever Vaccines Market Challenges
15.4 Classical Swine Fever Vaccines Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Classical Swine Fever Vaccines Sales (M Doses) Growth Rate by Source (2020-2026) (US$ Million)
Table 2. Global Classical Swine Fever Vaccines Sales (M Doses) Comparison by Sales Channel (2020-2026) (US$ Million)
Table 3. Global Market Classical Swine Fever Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Classical Swine Fever Vaccines Sales (M Doses) by Region (2015-2020)
Table 5. Global Classical Swine Fever Vaccines Sales Market Share by Region (2015-2020)
Table 6. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Classical Swine Fever Vaccines Revenue Share by Region (2015-2020)
Table 8. Global Classical Swine Fever Vaccines Sales (M Doses) Forecast by Region (2021-2026)
Table 9. Global Classical Swine Fever Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Classical Swine Fever Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Classical Swine Fever Vaccines Revenue Share Forecast by Region (2021-2026)
Table 12. Global Classical Swine Fever Vaccines (M Doses) of Key Companies (2015-2020)
Table 13. Global Classical Swine Fever Vaccines Sales Share by Company (2015-2020)
Table 14. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Classical Swine Fever Vaccines Revenue Share by Company (2015-2020)
Table 16. Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Classical Swine Fever Vaccines as of 2019)
Table 17. Global Classical Swine Fever Vaccines Average Price (USD/K Doses) of Key Company (2015-2020)
Table 18. Manufacturers Classical Swine Fever Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Classical Swine Fever Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Classical Swine Fever Vaccines Players
Table 22. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2015-2020)
Table 23. Global Classical Swine Fever Vaccines Sales Share by Source (2015-2020)
Table 24. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Source (2015-2020)
Table 25. Global Classical Swine Fever Vaccines Price (M Doses) by Source (2015-2020)
Table 26. Global Classical Swine Fever Vaccines Sales Share by Source (2021-2026)
Table 27. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Source (2021-2026)
Table 28. Global Classical Swine Fever Vaccines Revenue Share by Source (2021-2026)
Table 29. Global Classical Swine Fever Vaccines Price (M Doses) by Source (2021-2026)
Table 30. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2015-2020)
Table 31. Global Classical Swine Fever Vaccines Sales Share by Sales Channel (2015-2020)
Table 32. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Sales Channel (2015-2020)
Table 33. Global Classical Swine Fever Vaccines Price (M Doses) by Sales Channel (2015-2020)
Table 34. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2021-2026)
Table 35. Global Classical Swine Fever Vaccines Sales Share by Sales Channel (2021-2026)
Table 36. Global Classical Swine Fever Vaccines Revenue (US$ Million) Market Share by Sales Channel (2021-2026)
Table 37. Global Classical Swine Fever Vaccines Revenue Share by Sales Channel (2021-2026)
Table 38. Global Classical Swine Fever Vaccines Price (M Doses) by Sales Channel (2021-2026)
Table 39. United States Classical Swine Fever Vaccines Sales (M Doses) by Company (2015-2020)
Table 40. United States Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
Table 41. United States Classical Swine Fever Vaccines Sales (M Doses) by Source (2015-2020)
Table 42. United States Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
Table 43. United States Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2015-2020)
Table 44. United States Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
Table 45. Europe Classical Swine Fever Vaccines Sales (M Doses) by Company (2015-2020)
Table 46. Europe Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
Table 47. Europe Classical Swine Fever Vaccines Sales (M Doses) by Source (2015-2020)
Table 48. Europe Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
Table 49. Europe Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2015-2020)
Table 50. Europe Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
Table 51. China Classical Swine Fever Vaccines Sales (M Doses) by Company (2015-2020)
Table 52. China Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
Table 53. China Classical Swine Fever Vaccines Sales (M Doses) by Source (2015-2020)
Table 54. China Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
Table 55. China Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2015-2020)
Table 56. China Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
Table 57. Japan Classical Swine Fever Vaccines Sales (M Doses) by Company (2015-2020)
Table 58. Japan Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
Table 59. Japan Classical Swine Fever Vaccines Sales (M Doses) by Source (2015-2020)
Table 60. Japan Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
Table 61. Japan Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2015-2020)
Table 62. Japan Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
Table 63. Southeast Asia Classical Swine Fever Vaccines Sales (M Doses) by Company (2015-2020)
Table 64. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Classical Swine Fever Vaccines Sales (M Doses) by Source (2015-2020)
Table 66. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
Table 67. Southeast Asia Classical Swine Fever Vaccines Sales (M Doses) by Source (2015-2020)
Table 68. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2015-2020)
Table 69. India Classical Swine Fever Vaccines Sales (M Doses) by Company (2015-2020)
Table 70. India Classical Swine Fever Vaccines Sales Market Share by Company (2015-2020)
Table 71. India Classical Swine Fever Vaccines Sales (M Doses) by Source (2015-2020)
Table 72. India Classical Swine Fever Vaccines Sales Market Share by Source (2015-2020)
Table 73. India Classical Swine Fever Vaccines Sales (M Doses) by Application (2015-2020)
Table 74. India Classical Swine Fever Vaccines Sales Market Share by Application (2015-2020)
Table 75. WINSUN Corporation Information
Table 76. WINSUN Description and Business Overview
Table 77. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 78. WINSUN Classical Swine Fever Vaccines Product
Table 79. WINSUN Recent Development
Table 80. CAHIC Corporation Information
Table 81. CAHIC Description and Business Overview
Table 82. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 83. CAHIC Classical Swine Fever Vaccines Product
Table 84. CAHIC Recent Development
Table 85. Merial Corporation Information
Table 86. Merial Description and Business Overview
Table 87. Merial Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 88. Merial Classical Swine Fever Vaccines Product
Table 89. Merial Recent Development
Table 90. MSD Animal Health Corporation Information
Table 91. MSD Animal Health Description and Business Overview
Table 92. MSD Animal Health Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 93. MSD Animal Health Classical Swine Fever Vaccines Product
Table 94. MSD Animal Health Recent Development
Table 95. Chopper Biology Corporation Information
Table 96. Chopper Biology Description and Business Overview
Table 97. Chopper Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 98. Chopper Biology Classical Swine Fever Vaccines Product
Table 99. Chopper Biology Recent Development
Table 100. Ceva Corporation Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 103. Ceva Classical Swine Fever Vaccines Product
Table 104. Ceva Recent Development
Table 105. ChengDu Tecbond Corporation Information
Table 106. ChengDu Tecbond Description and Business Overview
Table 107. ChengDu Tecbond Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 108. ChengDu Tecbond Classical Swine Fever Vaccines Product
Table 109. ChengDu Tecbond Recent Development
Table 110. Veterinary Corporation Information
Table 111. Veterinary Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 112. Veterinary Description and Business Overview
Table 113. Veterinary Classical Swine Fever Vaccines Product
Table 114. Veterinary Recent Development
Table 115. Ringpu Biology Corporation Information
Table 116. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 117. Ringpu Biology Description and Business Overview
Table 118. Ringpu Biology Classical Swine Fever Vaccines Product
Table 119. Ringpu Biology Recent Development
Table 120. Qilu Animal Corporation Information
Table 121. Qilu Animal Description and Business Overview
Table 122. Qilu Animal Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 123. Qilu Animal Classical Swine Fever Vaccines Product
Table 124. Qilu Animal Recent Development
Table 125. DHN Corporation Information
Table 126. DHN Description and Business Overview
Table 127. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 128. DHN Classical Swine Fever Vaccines Product
Table 129. DHN Recent Development
Table 130. CAVAC Corporation Information
Table 131. CAVAC Description and Business Overview
Table 132. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 133. CAVAC Classical Swine Fever Vaccines Product
Table 134. CAVAC Recent Development
Table 135. Komipharm Corporation Information
Table 136. Komipharm Description and Business Overview
Table 137. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 138. Komipharm Classical Swine Fever Vaccines Product
Table 139. Komipharm Recent Development
Table 140. Agrovet Corporation Information
Table 141. Agrovet Description and Business Overview
Table 142. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 143. Agrovet Classical Swine Fever Vaccines Product
Table 144. Agrovet Recent Development
Table 145. Bioveta Corporation Information
Table 146. Bioveta Description and Business Overview
Table 147. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 148. Bioveta Classical Swine Fever Vaccines Product
Table 149. Bioveta Recent Development
Table 150. Jinyu Bio-Technology Corporation Information
Table 151. Jinyu Bio-Technology Description and Business Overview
Table 152. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 153. Jinyu Bio-Technology Classical Swine Fever Vaccines Product
Table 154. Jinyu Bio-Technology Recent Development
Table 155. Institutul Pasteur Corporation Information
Table 156. Institutul Pasteur Description and Business Overview
Table 157. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 158. Institutul Pasteur Classical Swine Fever Vaccines Product
Table 159. Institutul Pasteur Recent Development
Table 160. MVP Corporation Information
Table 161. MVP Description and Business Overview
Table 162. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 163. MVP Classical Swine Fever Vaccines Product
Table 164. MVP Recent Development
Table 165. Tecon Corporation Information
Table 166. Tecon Description and Business Overview
Table 167. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 168. Tecon Classical Swine Fever Vaccines Product
Table 169. Tecon Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Classical Swine Fever Vaccines Distributors List
Table 173. Classical Swine Fever Vaccines Customers List
Table 174. Classical Swine Fever Vaccines Market Key Trends
Table 175. Classical Swine Fever Vaccines Key Opportunities and Drivers
Table 176. Classical Swine Fever Vaccines Market Challenges
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Classical Swine Fever Vaccines Product Picture
Figure 2. Global Classical Swine Fever Vaccines Sales Market Share by Source in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Classical Swine Fever Vaccines Market Share by Sales Channel in 2020 & 2026
Figure 6. Government Tender Examples
Figure 7. Market Sales Examples
Figure 8. Global Classical Swine Fever Vaccines Sales (M Doses) Growth Rate (2015-2026)
Figure 9. Global Classical Swine Fever Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Classical Swine Fever Vaccines Price Trends Growth Rate (2015-2026) (USD/K Doses)
Figure 11. Global Classical Swine Fever Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Classical Swine Fever Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Classical Swine Fever Vaccines Sales (M Doses) Growth Rate (2015-2026)
Figure 15. Europe Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Classical Swine Fever Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Classical Swine Fever Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Classical Swine Fever Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Classical Swine Fever Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Classical Swine Fever Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Classical Swine Fever Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Classical Swine Fever Vaccines Players Market Share by Revenue in Classical Swine Fever Vaccines 2015 & 2019
Figure 26. Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Classical Swine Fever Vaccines Revenue Share by Source (2015-2020)
Figure 28. Global Classical Swine Fever Vaccines Revenue Growth Rate by Source in 2015 & 2019
Figure 29. Global Classical Swine Fever Vaccines Revenue Share by Sales Channel (2015-2020)
Figure 30. Global Classical Swine Fever Vaccines Revenue Growth Rate by Sales Channel in 2015 & 2019
Figure 31. United States Classical Swine Fever Vaccines Sales Market Share by Source in 2019
Figure 32. United States Classical Swine Fever Vaccines Sales Market Share by Source in 2019
Figure 33. Europe Classical Swine Fever Vaccines Sales Market Share by Company in 2019
Figure 34. Europe Classical Swine Fever Vaccines Sales Market Share by Source in 2019
Figure 35. Europe Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2019
Figure 36. China Classical Swine Fever Vaccines Sales Market Share by Company in 2019
Figure 37. China Classical Swine Fever Vaccines Sales Market Share by Source in 2019
Figure 38. China Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2019
Figure 39. Japan Classical Swine Fever Vaccines Sales Market Share by Company in 2019
Figure 40. Japan Classical Swine Fever Vaccines Sales Market Share by Source in 2019
Figure 41. Japan Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2019
Figure 42. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Company in 2019
Figure 43. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Source in 2019
Figure 44. Southeast Asia Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2019
Figure 45. India Classical Swine Fever Vaccines Sales Market Share by Company in 2019
Figure 46. India Classical Swine Fever Vaccines Sales Market Share by Source in 2019
Figure 47. India Classical Swine Fever Vaccines Sales Market Share by Sales Channel in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Classical Swine Fever Vaccines
Figure 50. Manufacturing Process Analysis of Classical Swine Fever Vaccines
Figure 51. Classical Swine Fever Vaccines Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
豚用ワクチンの世界市場レポート2020 The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination. Vaccines contain antigens from vi…- クラシカルバスレリーフの世界市場レポート2020 Market Analysis and Insights: Global Classical Bas Relief Market The global Classical Bas Relief market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Classical Bas Relief Scope and Market Size The global Classical Bas Relief…
- 豚生殖・呼吸器症候群ワクチンの世界市場レポート2020 Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Boehringer ingelheim is the company with the largest market share, about 25 percent. Market Analysis and Insights: Global S…
- トラベラーズワクチンの世界市場レポート2020 A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates …
- 獣医用クロストリジウムワクチンの世界市場レポート2020 Market Analysis and Insights: Global Veterinary Clostridium Vaccines Market The global Veterinary Clostridium Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Veterinary Clostridium Vaccines Scope and Market Siz…